Trademark: 87825579
Status Date
Wednesday, October 11, 2023
Filing Date
Thursday, March 8, 2018
9 Electronic databases in the fields of drug development and drug manufacturing, recorded on computer media; bioinformatics software for storing, indexing, searching, retrieving, and accessing information about biological data for use in retrosynthesis, optimization of organic chemistry reactions and synthesis, assessing synthetic accessibility of real and virtual molecules, and drug discovery, drug development, and drug manufacturing; chemoinformatics software for storing, indexing, searching, retrieving, and accessing information about chemical compounds and chemical data for use in retrosynthesis, optimization of organic chemistry reactions and synthesis, assessing synthetic accessibility of real and virtual molecules, drug discovery, drug development, and drug manufacturing; software for use in biological and chemical modelling, analysis and information management for use in retrosynthesis, optimization of organic chemistry reactions and synthesis, assessing synthetic accessibility of real and virtual molecules, drug discovery, drug development, and drug manufacturing; software for computer-aided molecular design, data processing and data analysis for use in retrosynthesis, optimization of organic chemistry reactions and synthesis, assessing synthetic accessibility of real and virtual molecules, drug discovery, drug development, and drug manufacturing; chemical data analysis software for use in retrosynthesis, optimization of organic chemistry reactions and synthesis, assessing synthetic accessibility of real and virtual molecules, drug discovery, drug development, and drug manufacturing; drug discovery information systems software used to solve problems in connection with chemical syntheses for use in the field of organic chemistry; ; none of the foregoing for use in connection with synthetic patients, simulated patients, synthetic electronic patient healthcare records, synthetic patient data and associated healthcare records, nor in the field of medical science and medical consultancy
38 Providing access to databases for use in retrosynthesis, optimization of organic chemistry reactions and synthesis, assessing synthetic accessibility of real and virtual molecules, drug discovery, drug development, and drug manufacturing; none of the foregoing for use in connection with synthetic patients, simulated patients, synthetic electronic patient healthcare records, synthetic patient data and associated healthcare records, nor in the field of medical science and medical consultancy
45 Licensing of computer software used for retrosynthesis, optimization of organic chemistry reactions and synthesis, assessing synthetic accessibility of real and virtual molecules, drug discovery, drug development, and drug manufacturing ; none of the foregoing for use in connection with synthetic patients, simulated patients, synthetic electronic patient healthcare records, synthetic patient data and associated healthcare records, nor in the field of medical science and medical consultancy
42 Biotechnology and pharmaceutical research relating to retrosynthesis, optimization of organic chemistry reactions and synthesis, assessing synthetic accessibility of real and virtual molecules, and drug development; professional consultancy in relation to drug development; scientific research and development for others; scientific research in the nature of analysis and preparation of data relating to retrosynthesis, optimization of organic chemistry reactions and synthesis, assessing synthetic accessibility of real and virtual molecules, drug discovery and drug development; provision of information in relation to drug discovery and drug development; provision of scientific information related to pharmacy; none of the foregoing for use in connection with synthetic patients, simulated patients, synthetic electronic patient healthcare records, synthetic patient data and associated healthcare records, nor in the field of medical science and medical consultancy
Oct 11, 2023
Report Completed Suspension Check Case Still Suspended
Oct 11, 2023
Suspension Checked - To Attorney For Action
Mar 3, 2023
Report Completed Suspension Check Case Still Suspended
Mar 2, 2023
Suspension Checked - To Attorney For Action
Feb 14, 2023
Assigned To Examiner
Nov 30, 2022
Suspension Checked - To Attorney For Action
Apr 28, 2022
Notification Of Letter Of Suspension E-Mailed
Apr 28, 2022
Letter Of Suspension E-Mailed
Apr 28, 2022
Suspension Letter Written
Feb 21, 2022
Teas/Email Correspondence Entered
Feb 21, 2022
Correspondence Received In Law Office
Feb 21, 2022
Teas Response To Office Action Received
Nov 3, 2021
Assigned To Examiner
Aug 23, 2021
Notification Of Non-Final Action E-Mailed
Aug 23, 2021
Non-Final Action E-Mailed
Aug 23, 2021
Non-Final Action Written
Jun 26, 2021
Suspension Checked - To Attorney For Action
Jun 23, 2020
Report Completed Suspension Check Case Still Suspended
Jun 22, 2020
Assigned To Lie
Dec 20, 2019
Report Completed Suspension Check Case Still Suspended
Jun 10, 2019
Notification Of Letter Of Suspension E-Mailed
Jun 10, 2019
Letter Of Suspension E-Mailed
Jun 10, 2019
Suspension Letter Written
May 20, 2019
Teas/Email Correspondence Entered
May 20, 2019
Correspondence Received In Law Office
May 16, 2019
Assigned To Lie
May 9, 2019
Teas Response To Suspension Inquiry Received
Mar 19, 2019
Notification Of Letter Of Suspension E-Mailed
Mar 19, 2019
Letter Of Suspension E-Mailed
Mar 19, 2019
Suspension Letter Written
Mar 12, 2019
Teas/Email Correspondence Entered
Mar 11, 2019
Correspondence Received In Law Office
Mar 11, 2019
Teas Response To Office Action Received
Nov 8, 2018
Notification Of Non-Final Action E-Mailed
Nov 8, 2018
Non-Final Action E-Mailed
Nov 8, 2018
Non-Final Action Written
Oct 2, 2018
Teas/Email Correspondence Entered
Oct 2, 2018
Correspondence Received In Law Office
Oct 2, 2018
Teas Response To Office Action Received
Apr 4, 2018
Notification Of Non-Final Action E-Mailed
Apr 4, 2018
Non-Final Action E-Mailed
Apr 4, 2018
Non-Final Action Written
Mar 27, 2018
Assigned To Examiner
Mar 14, 2018
New Application Office Supplied Data Entered
Mar 12, 2018
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
